Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

811 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial.
Roncalli J, Roubille F, Meyer N, Pompilio G, Leroux L, Henon P, Trebuchet G, Criquet A, de Kalbermatten M, Saloux E, Manrique A, Marie PY, Bhatt DL, Solomon SD, Montalescot G, Newby DE, Zannad F; EXCELLENT Trial Investigators. Roncalli J, et al. Among authors: montalescot g. ESC Heart Fail. 2024 Dec 15. doi: 10.1002/ehf2.15124. Online ahead of print. ESC Heart Fail. 2024. PMID: 39676512 Free article.
Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk.
Roffi M, Landi A, Heg D, Frigoli E, Chalkou K, Chevalier B, Ijsselmuiden AJJ, Kastberg R, Komiyama N, Morice MC, Onuma Y, Ozaki Y, Peace A, Pyxaras S, Sganzerla P, Williams R, Xaplanteris P, Vranckx P, Windecker S, Smits PC, Valgimigli M; MASTER DAPT Investigators. Roffi M, et al. JACC Cardiovasc Interv. 2024 Nov 25;17(22):2664-2677. doi: 10.1016/j.jcin.2024.08.030. JACC Cardiovasc Interv. 2024. PMID: 39603779 Clinical Trial.
Colchicine in Acute Myocardial Infarction.
Jolly SS, d'Entremont MA, Lee SF, Mian R, Tyrwhitt J, Kedev S, Montalescot G, Cornel JH, Stanković G, Moreno R, Storey RF, Henry TD, Mehta SR, Bossard M, Kala P, Layland J, Zafirovska B, Devereaux PJ, Eikelboom J, Cairns JA, Shah B, Sheth T, Sharma SK, Tarhuni W, Conen D, Tawadros S, Lavi S, Yusuf S; CLEAR Investigators. Jolly SS, et al. Among authors: montalescot g. N Engl J Med. 2024 Nov 17. doi: 10.1056/NEJMoa2405922. Online ahead of print. N Engl J Med. 2024. PMID: 39555823
Routine Spironolactone in Acute Myocardial Infarction.
Jolly SS, d'Entremont MA, Pitt B, Lee SF, Mian R, Tyrwhitt J, Kedev S, Montalescot G, Cornel JH, Stanković G, Moreno R, Storey RF, Henry TD, Mehta SR, Bossard M, Kala P, Bhindi R, Zafirovska B, Devereaux PJ, Eikelboom J, Cairns JA, Natarajan MK, Schwalm JD, Sharma SK, Tarhuni W, Conen D, Tawadros S, Lavi S, Asani V, Topic D, Cantor WJ, Bertrand OF, Pourdjabbar A, Yusuf S; CLEAR investigators. Jolly SS, et al. Among authors: montalescot g. N Engl J Med. 2024 Nov 17. doi: 10.1056/NEJMoa2405923. Online ahead of print. N Engl J Med. 2024. PMID: 39555814
Response by Yan et al to Letter Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
Yan Y, Nie S, Montalescot G. Yan Y, et al. Among authors: montalescot g. Circulation. 2024 Nov 12;150(20):e445-e446. doi: 10.1161/CIRCULATIONAHA.124.071534. Epub 2024 Nov 11. Circulation. 2024. PMID: 39527656 No abstract available.
Defective biological activities of high-density lipoprotein identify patients at highest risk of recurrent cardiovascular event.
Silvain J, Materne C, Zeitouni M, Procopi N, Guedeney P, Brugier D, Galier S, Lhomme M, Ponnaiah M, Guillas I, Kc P, Dahik VD, Frisdal E, Vicaut E, Lesnik P, Rahoual G, Le Goff W, Montalescot G, Kerneis M, Guerin M. Silvain J, et al. Among authors: montalescot g. Eur J Prev Cardiol. 2024 Nov 7:zwae356. doi: 10.1093/eurjpc/zwae356. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 39506545
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial.
Motovska Z, Hlinomaz O, Mrozek J, Kala P, Geisler T, Hromadka M, Akin I, Precek J, Kettner J, Cervinka P, Montalescot G, Jarkovsky J, Belohlavek J, Bis J, Matejka J, Vodzinska A, Muzafarova T, Tomasov P, Schee A, Bartus S, Andrasova A, Olivier CB, Kovarik A, Ostadal P, Demlova R, Souckova L, Vulev I, Coufal Z, Kochman J, Marinov I, Kubica J, Ducrocq G, Karpisek M, Klimsa Z, Hudec M, Widimsky P, Bhatt DL, Group DS. Motovska Z, et al. Among authors: montalescot g. EuroIntervention. 2024 Oct 21;20(20):e1309-e1318. doi: 10.4244/EIJ-D-24-00203. EuroIntervention. 2024. PMID: 39432252 Free article.
Levosimendan in Patients with Cardiogenic Shock Refractory to Dobutamine Weaning.
Zeitouni M, Dorvillius E, Sulman D, Procopi N, Beaupré F, Devos P, Barthélémy O, Rouanet S, Ferrante A, Chommeloux J, Hekimian G, Kerneis M, Silvain J, Montalescot G; ACTION Study Group. Zeitouni M, et al. Among authors: montalescot g. Am J Cardiovasc Drugs. 2024 Oct 21. doi: 10.1007/s40256-024-00683-z. Online ahead of print. Am J Cardiovasc Drugs. 2024. PMID: 39432228
Characteristics of Young Women Presenting With Acute Myocardial Infarction: The Prospective, Multicenter, Observational Young Women Presenting Acute Myocardial Infarction in France Study.
Manzo-Silberman S, Couturaud F, Bellemain-Appaix A, Vautrin E, Gompel A, Drouet L, Marliere S, Sollier CBD, Uhry S, Eltchaninoff H, Bergot T, Motreff P, Lahlou N, Cottin Y, Mounier-Vehier C, Gilard M, Montalescot G; WAMIF Investigators. Manzo-Silberman S, et al. Among authors: montalescot g. J Am Heart Assoc. 2024 Oct;13(19):e034456. doi: 10.1161/JAHA.124.034456. Epub 2024 Sep 25. J Am Heart Assoc. 2024. PMID: 39319493 Free article.
811 results